The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Wyss Institute Receives Grant from Cystic Fibrosis Foundation
Infectious Disease & AMR

Wyss Institute Receives Grant from Cystic Fibrosis Foundation

OCT 18, 2018
LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University
Pharma & Human Health

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

OCT 17, 2018
Microsoft Genomics Ventures into the Microbiome With Eagle Genomics
Animal Health

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

OCT 15, 2018
MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD

OCT 15, 2018
Synthetic Biologics Prices $18,000,000 Public Offering
Finance

Synthetic Biologics Prices $18,000,000 Public Offering

OCT 12, 2018
Researchers Link Gut Bacteria to Heart Transplant Success or Failure
Pharma & Human Health

Researchers Link Gut Bacteria to Heart Transplant Success or Failure

OCT 11, 2018
Valbiotis Appoints Murielle Cazaubiel as Head of Development and Medical Affairs
Pharma & Human Health

Valbiotis Appoints Murielle Cazaubiel as Head of Development and Medical Affairs

OCT 10, 2018
DNAnexus-Powered Mosaic Microbiome Platform Announces Winners of Second Community Challenge
Pharma & Human Health

DNAnexus-Powered Mosaic Microbiome Platform Announces Winners of Second Community Challenge

OCT 5, 2018
Gram-negative Bacteria Increase Mortality, Vasopressor use and ICU Admission in ILD Patients
Pharma & Human Health

Gram-negative Bacteria Increase Mortality, Vasopressor use and ICU Admission in ILD Patients

OCT 5, 2018
Vedanta Biosciences Announces Successful Phase 1a/1b Data for Lead, Rationally Defined Bacterial Consortium Product Candidate
Infectious Disease & AMR

Vedanta Biosciences Announces Successful Phase 1a/1b Data for Lead, Rationally Defined Bacterial Consortium Product Candidate

OCT 4, 2018
Reading Between the Lines: What the FDA Public Workshop Really Tells Us About the Regulation of Microbiome-Based Products
Editor's Choice

Reading Between the Lines: What the FDA Public Workshop Really Tells Us About the Regulation of Microbiome-Based Products

OCT 3, 2018